A gene expression signature of TREM2^hi macrophages and γδ T cells predicts immunotherapy response

Keyphrases

• T Cells 100%
• Gene Signature 100%
• Macrophage Cells 100%
• Immunotherapy Response 100%
• Immune Checkpoint Therapy 100%
• Melanoma 66%
• Publicly Available 66%
• Immune Parameters 66%
• Single-cell RNA Sequencing (scRNA-seq) 66%
• Cancer Patients 33%
• Macrophages 33%
• Overexpressing 33%
• Tumor 33%
• Non-responders 33%
• Clinical Decision-making 33%
• Response Predictors 33%
• Predictive Biomarker 33%
• Gene Characteristics 33%
• Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) 33%
• B Cell Subsets 33%
• Response to Immunotherapy 33%
• Bulk RNA-seq 33%
• RNA-seq Datasets 33%
• Gamma delta T Cells 33%

Immunology and Microbiology

• Macrophage 100%
• T Cell 100%
• Immunotherapy 100%
• Gene Expression Assay 100%
• Immunocompetent Cell 100%
• RNA Sequence 100%
• Immunotherapy Response 100%
• Clinical Decision Making 50%
• B Lymphocyte Subpopulation 50%
• RNA Sequencing 50%

Biochemistry, Genetics and Molecular Biology

• Gene Expression Profiling 100%
• Macrophage 100%
• T Cell 100%
• Immune Checkpoints 100%
• Immunocompetent Cell 66%
• RNA Sequence 66%
• Clinical Decision Making 33%
• B Lymphocyte Subpopulation 33%
• TREM2 33%
• Bulk RNA Sequencing 33%